385 related articles for article (PubMed ID: 32193546)
41. Efficacy and Safety of Adjuvant Proton Therapy Combined With Surgery for Chondrosarcoma of the Skull Base: A Retrospective, Population-Based Study.
Feuvret L; Bracci S; Calugaru V; Bolle S; Mammar H; De Marzi L; Bresson D; Habrand JL; Mazeron JJ; Dendale R; Noël G
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):312-321. PubMed ID: 26883563
[TBL] [Abstract][Full Text] [Related]
42. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
Gillmann C; Jäkel O; Karger CP
Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
[TBL] [Abstract][Full Text] [Related]
43. Results of carbon ion radiotherapy in 152 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
[TBL] [Abstract][Full Text] [Related]
44. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
45. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
[TBL] [Abstract][Full Text] [Related]
46. Active raster scanning with carbon ions: reirradiation in patients with recurrent skull base chordomas and chondrosarcomas.
Uhl M; Welzel T; Oelmann J; Habl G; Hauswald H; Jensen A; Ellerbrock M; Debus J; Herfarth K
Strahlenther Onkol; 2014 Jul; 190(7):686-91. PubMed ID: 24663287
[TBL] [Abstract][Full Text] [Related]
47. The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignancies.
Holtzman AL; Rutenberg MS; De Leo AN; Rao D; Patel J; Morris CG; Indelicato DJ; Mendenhall WM
Acta Oncol; 2022 Aug; 61(8):1026-1031. PubMed ID: 35897132
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy.
Lim PS; Tran S; Kroeze SGC; Pica A; Hrbacek J; Bachtiary B; Walser M; Leiser D; Lomax AJ; Weber DC
Pediatr Blood Cancer; 2020 Dec; 67(12):e28664. PubMed ID: 32881313
[TBL] [Abstract][Full Text] [Related]
49. Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas.
Noël G; Feuvret L; Ferrand R; Boisserie G; Mazeron JJ; Habrand JL
Neurosurgery; 2004 Dec; 55(6):1252-60; discussion 1260-2. PubMed ID: 15574207
[TBL] [Abstract][Full Text] [Related]
50. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
51. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.
Nikoghosyan AV; Rauch G; Münter MW; Jensen AD; Combs SE; Kieser M; Debus J
BMC Cancer; 2010 Nov; 10():606. PubMed ID: 21050498
[TBL] [Abstract][Full Text] [Related]
52. A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment.
Baumann BC; Lustig RA; Mazzoni S; Grady SM; O'Malley BW; Lee JYK; Newman JG; Schuster JM; Both S; Lin A; Dorsey JF; Alonso-Basanta M
J Surg Oncol; 2019 Aug; 120(2):200-205. PubMed ID: 31111502
[TBL] [Abstract][Full Text] [Related]
53. Local Control After Proton Therapy for Pediatric Chordoma.
Indelicato DJ; Rotondo RL; Mailhot Vega RB; Holtzman AL; Looi WS; Morris CG; Sandler ES; Aldana PR; Bradley JA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1406-1413. PubMed ID: 33253819
[TBL] [Abstract][Full Text] [Related]
54. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma.
De Leo AN; Holtzman AL; Ho MW; Morris CG; Rutenberg MS; Rotondo RL; Bates JE; Indelicato DJ; Rao D; Asa Hasan M; Mendenhall WM
Radiother Oncol; 2021 May; 158():125-130. PubMed ID: 33610625
[TBL] [Abstract][Full Text] [Related]
55. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
[TBL] [Abstract][Full Text] [Related]
56. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma.
Terahara A; Niemierko A; Goitein M; Finkelstein D; Hug E; Liebsch N; O'Farrell D; Lyons S; Munzenrider J
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):351-8. PubMed ID: 10487555
[TBL] [Abstract][Full Text] [Related]
58. Clinical results of proton beam therapy for skull base chordoma.
Igaki H; Tokuuye K; Okumura T; Sugahara S; Kagei K; Hata M; Ohara K; Hashimoto T; Tsuboi K; Takano S; Matsumura A; Akine Y
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1120-6. PubMed ID: 15519783
[TBL] [Abstract][Full Text] [Related]
59. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base.
Combs SE; Nikoghosyan A; Jaekel O; Karger CP; Haberer T; Münter MW; Huber PE; Debus J; Schulz-Ertner D
Cancer; 2009 Mar; 115(6):1348-55. PubMed ID: 19156905
[TBL] [Abstract][Full Text] [Related]
60. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
